Person of the Year
On May 15, at the Person of the Year Awards Gala Dinner in New York City, the Brazilian-American Chamber of Commerce welcomed The Medulloblastoma Initiative (MBI)...
A milestone for MBI
Scientists, academics, researchers, entrepreneurs, and media personalities gathered last Wednesday (May 10th) at the Brazilian Embassy in Washington, D.C...
To save a life: Lessons for launching a medical R&D initiative
In February 2024, MBI was featured eJewish Philanthropy, a news publication covering the world of Jewish philanthropy. The platform engages in daily discussions via original reporting...
The quest for a cure for medulloblastoma
Last saturday (23), MBI founder Fernando Goldsztein participated in the Present-Future session of Snola 2024, the largest scientific event in neuro-oncology in Latin America...
MBI at the largest scientific event in neuro-oncology in Latin America
Last saturday (23), MBI founder Fernando Goldsztein participated in the Present-Future session of Snola 2024, the largest scientific event in neuro-oncology in Latin America...
A big step for MBI
On March 6th, wednesday, the story of The Medulloblastoma Initiative (MBI) was presented to the Permanent Council of the OAS (Organization of American States @oea_oficial ) in Washington D.C., during the session dedicated to World Rare Disease Day.
United voices at the International Pediatric Neuro-Oncology Symposium
United voices at the International Pediatric Neuro-Oncology Symposium in Porto Alegre, Brazil: "In many places around the world, medulloblastoma is still being diagnosed...
Brazil-American Chamber of Commerce Webinar
A Novel Approach: Brazil-US Partnerships in Health Science and Human Medicine — was the webinar hosted last Friday, October 27...
Valued Connections
Decades of innovation, courage, and creativity on the same stage: as alumni of the Catholic University of Rio Grande do Sul (PUCRS), Brazil, Fernando Goldsztein (MBI), Dr. Maira Caleff (IMAMA), and Dr. Jorge Audy (Tecnopuc) brilliantly kicked off the first edition of Valued Connections...
Clinical trials just
around the corner
Dr. Duane Mitchell's research includes pioneering clinical studies in medulloblastoma (Re-MATCH) and gliomas (PEACH), which have confirmed the potential of this approach as a platform for cure. In the following interview, Dr. Mitchell...
